Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

Related Citations for PubMed (Select 23510124)

1.

Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial.

Marquez-Romero JM, Arauz A, Ruiz-Sandoval JL, Cruz-Estrada Ede L, Huerta-Franco MR, Aguayo-Leytte G, Ruiz-Franco A, Silos H.

Trials. 2013 Mar 19;14:77. doi: 10.1186/1745-6215-14-77.

2.

Listening to fluoxetine: a hot message from the FLAME trial of poststroke motor recovery.

Cramer SC.

Int J Stroke. 2011 Aug;6(4):315-6. doi: 10.1111/j.1747-4949.2011.00618.x.

PMID:
21745341
3.

Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial.

Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, Bejot Y, Deltour S, Jaillard A, Niclot P, Guillon B, Moulin T, Marque P, Pariente J, Arnaud C, Loubinoux I.

Lancet Neurol. 2011 Feb;10(2):123-30. doi: 10.1016/S1474-4422(10)70314-8. Epub 2011 Jan 7. Erratum in: Lancet Neurol. 2011 Mar;10(3):205.

PMID:
21216670
5.

Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.

Robinson RG, Schultz SK, Castillo C, Kopel T, Kosier JT, Newman RM, Curdue K, Petracca G, Starkstein SE.

Am J Psychiatry. 2000 Mar;157(3):351-9.

PMID:
10698809
6.

Neurosurgical outcomes after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST).

Steiner T, Vincent C, Morris S, Davis S, Vallejo-Torres L, Christensen MC.

J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4):287-94. doi: 10.1016/j.jstrokecerebrovasdis.2009.12.008. Epub 2010 May 8.

PMID:
20452785
7.
8.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

9.

The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial.

Meretoja A, Churilov L, Campbell BC, Aviv RI, Yassi N, Barras C, Mitchell P, Yan B, Nandurkar H, Bladin C, Wijeratne T, Spratt NJ, Jannes J, Sturm J, Rupasinghe J, Zavala J, Lee A, Kleinig T, Markus R, Delcourt C, Mahant N, Parsons MW, Levi C, Anderson CS, Donnan GA, Davis SM.

Int J Stroke. 2014 Jun;9(4):519-24. doi: 10.1111/ijs.12132. Epub 2013 Aug 26.

PMID:
23981692
10.
12.

Telerehabilitation to improve outcomes for people with stroke: study protocol for a randomised controlled trial.

Saywell N, Vandal AC, Brown P, Hanger HC, Hale L, Mudge S, Milosavljevic S, Feigin V, Taylor D.

Trials. 2012 Dec 5;13:233. doi: 10.1186/1745-6215-13-233.

13.

Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials.

Cucchiara B, Kasner SE, Tanne D, Levine SR, Demchuk A, Messe SR, Sansing L, Lees KR, Lyden P; SAINT Investigators.

Stroke. 2009 Sep;40(9):3067-72. doi: 10.1161/STROKEAHA.109.554386. Epub 2009 Jul 16.

14.

Cooling in intracerebral hemorrhage (CINCH) trial: protocol of a randomized German-Austrian clinical trial.

Kollmar R, Juettler E, Huttner HB, Dörfler A, Staykov D, Kallmuenzer B, Schmutzhard E, Schwab S, Broessner G; CINCH investigators.

Int J Stroke. 2012 Feb;7(2):168-72. doi: 10.1111/j.1747-4949.2011.00707.x.

PMID:
22264371
15.

Depressed mood after intracerebral hemorrhage: the FAST trial.

Christensen MC, Mayer SA, Ferran JM, Kissela B.

Cerebrovasc Dis. 2009;27(4):353-60. doi: 10.1159/000202012. Epub 2009 Feb 14.

PMID:
19218801
16.

Association between disability measures and short-term health care costs following intracerebral hemorrhage.

Christensen MC, Morris S.

Neurocrit Care. 2008;9(3):313-8. doi: 10.1007/s12028-008-9124-5. Epub 2008 Aug 12.

PMID:
18696272
17.

Quality of life after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.

Christensen MC, Mayer S, Ferran JM.

Stroke. 2009 May;40(5):1677-82. doi: 10.1161/STROKEAHA.108.538967. Epub 2009 Mar 5.

18.

Chinese medicine NeuroAiD efficacy stroke recovery-extension study (CHIMES-E study): an observational multicenter study to investigate the longer-term efficacy of NeuroAiD in stroke recovery.

Venketasubramanian N, Young S, Tay SS, Chang HM, Umapathi T, Chan B, de Silva A, Wong L, Navarro J, Zhao YD, Tan SB, Chen C.

Cerebrovasc Dis. 2013;35 Suppl 1:18-22. doi: 10.1159/000346233. Epub 2013 Mar 14.

PMID:
23548915
19.

Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.

Chen CL, Young SH, Gan HH, Singh R, Lao AY, Baroque AC 2nd, Chang HM, Hiyadan JH, Chua CL, Advincula JM, Muengtaweepongsa S, Chan BP, de Silva HA, Towanabut S, Suwanwela NC, Poungvarin N, Chankrachang S, Wong KS, Eow GB, Navarro JC, Venketasubramanian N, Lee CF, Bousser MG; CHIMES Study Investigators.

Stroke. 2013 Aug;44(8):2093-100. doi: 10.1161/STROKEAHA.113.002055. Epub 2013 Jun 18.

20.

Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in acute lung injury to reduce pulmonary dysfunction (HARP-2) trial: study protocol for a randomized controlled trial.

McAuley DF, Laffey JG, O'Kane CM, Cross M, Perkins GD, Murphy L, McNally C, Crealey G, Stevenson M; HARP-2 investigators; Irish Critical Care Trials Group.

Trials. 2012 Sep 17;13:170. doi: 10.1186/1745-6215-13-170.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk